Table 6. Clinical status and ICAM-1 genotypic frequencies in 595 oral cancer patients.

Variable	rs3093030			rs5491			rs281432			rs5498
	CC (N = 384)	CT+TT (N = 211)	p value	AA (N = 537)	AT+TT (N = 58)	p value	CC (N = 332)	CG+GG (N = 263)	p value	AA (N = 329)	AG+GG (N = 266)	p value
Clinical Stage
Stage I/II	168 (43.8%)	93 (44.1%)	0.939	226 (42.1%)	35 (60.3%)	0.008 *	131 (39.5%)	130 (49.4%)	0.015 *	136 (41.3%)	125 (47.0%)	0.167
Stage III/IV	216 (56.2%)	118 (55.9%)		311 (57.9%)	23 (39.7%)		201 (60.5%)	133 (50.6%)		193 (58.7%)	141 (53.0%)
Tumor size
≤T2	239 (62.2%)	124 (58.8%)	0.406	322 (60.0%)	41 (70.7%)	0.112	193 (58.1%)	170 (64.6%)	0.106	195 (59.3%)	168 (63.2%)	0.334
>T2	145 (37.8%)	87 (41.2%)		215 (40.0%)	17 (29.3%)		139 (41.9%)	93 (35.4%)		134 (40.7%)	98 (36.8%)
Lymph node metastasis
No	242 (63.0%)	137 (64.9%)	0.643	337 (62.8%)	42 (72.4%)	0.146	208 (62.7%)	171 (65.0%)	0.551	206 (62.6%)	173 (65.0%)	0.541
Yes	142 (37.0%)	74 (35.1%)		200 (37.2%)	16 (27.6%)		124 (37.3%)	92 (35.0%)		123 (37.4%)	93 (35.0%)
Distant metastasis
No	378 (98.7%)	209 (98.5%)	0.533	529 (98.5%)	58 (100.0%)	0.349	325 (97.9%)	262 (99.6%)	0.069	322 (97.9%)	35 (99.6%)	0.065
Yes	6 (1.6%)	2 (0.9%)		8 (1.5%)	0 (0%)		7 (2.1%)	1 (0.4%)		7 (2.1%)	1 (0.4%)

T2: tumor size >2 cm in the greatest dimension.

^*P value<0.05 as statistically significant.